Could pharmacist-prescribing reduce chemotherapy errors?
Shannon Nally is a pharmacist with a strong background in aseptic pharmacy work and oncology. Whilst studying for a master’s degree at University College Cork (UCC) she undertook […]
Shannon Nally is a pharmacist with a strong background in aseptic pharmacy work and oncology. Whilst studying for a master’s degree at University College Cork (UCC) she undertook […]
Chemotherapy prescribing is an “error-prone process” according to Shannon Nally, the author of a study conducted at University Hospital, Limerick. The findings suggest that prescribing of chemotherapy by […]
Shannon Nally is a pharmacist with a strong background in aseptic pharmacy work and oncology. Whilst studying for a master’s degree at University College Cork (UCC) she undertook […]
Alex Miras is Professor of Endocrinology at the University of Ulster, UK and is an expert in obesity management and research. In 2021 a trial of semaglutide for […]
Professor Alex Miras, consultant endocrinologist at the University of Ulster, takes the view that obesity is a disease. He explains why this is and how the SELECT trial […]
Semaglutide works well on its own as obesity treatment but it works even better with the support and guidance of a multi-disciplinary weight-management team, according to Alex Miras, […]
In March 2023 the National Institute for Health and Care Excellence (NICE) published Technology Appraisal Guidance for semaglutide for obesity. Professor Alex Miras explains the guidance and its […]
Alex Miras is Professor of Endocrinology at the University of Ulster, UK and is an expert in obesity management and research. In 2021 a trial of semaglutide for […]
Debi Bhattacharya is Professor of Behavioural Medicine at the University of Leicester, UK. As a former primary care pharmacist, she has experience of both practice and research into […]
The CHARMER study of a proactive deprescribing intervention is different from previous studies and addresses five critical factors identified by prescribers and patients as being key to success, […]
There is no ‘one-size-fits-all’ deprescribing intervention and a good understanding of the barriers and enablers to effective deprescribing is needed, according to Debi Bhattacharya, Professor of Behavioural Medicine […]
Debi Bhattacharya is Professor of Behavioural Medicine at the University of Leicester, UK. As a former primary care pharmacist, she has experience of both practice and research into […]